Cutler Group LP Fate Therapeutics Inc Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 Apr 26, 2021	SELL	$72.16 - $117.4 $14,432 - $23,480	-200 Reduced 50.0%	200 $0
Q4 2020 Jan 21, 2021	SELL	$38.09 - $100.95 $34,281 - $90,855	-900 Reduced 69.23%	400 $0
Q3 2020 Oct 27, 2020	BUY	$30.41 - $40.5 $9,123 - $12,150	300 Added 30.0%	1,300 $0
Q2 2020 Jul 22, 2020	SELL	$20.21 - $35.23 $90,945 - $158,535	-4,500 Reduced 81.82%	1,000 $0
Q4 2019 Feb 06, 2020	BUY	$13.39 - $20.73 $73,645 - $114,015	5,500 New	5,500 $1,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $163M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.